These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9889663)
1. [Treatment of hereditary and malignant diseases by regulating genetic transcription?]. Skovby F Ugeskr Laeger; 1998 Dec; 160(51):7447. PubMed ID: 9889663 [No Abstract] [Full Text] [Related]
2. Engineering the immune system to cure genetic diseases, HIV, and cancer. Porteus MH; Fischer A Curr Opin Immunol; 2012 Oct; 24(5):576-9. PubMed ID: 23084086 [No Abstract] [Full Text] [Related]
3. The challenge of using SNPs in the understanding and treatment of disease. Schifreen RS; Storts DR; Buller AM Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392 [No Abstract] [Full Text] [Related]
4. [Made-to-order therapy using the gene profile]. Kathmann W Dtsch Med Wochenschr; 2007 Nov; 132(48):p25. PubMed ID: 18033648 [No Abstract] [Full Text] [Related]
5. [Is 'exon-skipping' a molecular therapy for hereditary diseases?]. Berneburg M Hautarzt; 2008 Mar; 59(3):257-8. PubMed ID: 18309529 [No Abstract] [Full Text] [Related]
6. [Molecular genetic mechanisms and hereditary disease]. Nesland JM Tidsskr Nor Laegeforen; 1999 Feb; 119(6):779. PubMed ID: 10101934 [No Abstract] [Full Text] [Related]
7. [The study and correction of gene defects in hereditary diseases]. Neĭfakh SA Vestn Akad Med Nauk SSSR; 1981; (12):23-32. PubMed ID: 6949414 [No Abstract] [Full Text] [Related]
8. Encapsulated, genetically modified cells producing in vivo therapeutics. Hauser O; Prieschl-Grassauer E; Salmons B Curr Opin Mol Ther; 2004 Aug; 6(4):412-20. PubMed ID: 15468600 [TBL] [Abstract][Full Text] [Related]
9. [Antisense oligonucleotides arrest the synthesis of disease promoting proteins]. Schnädelbach S Med Monatsschr Pharm; 1998 Dec; 21(12):394-5. PubMed ID: 9925458 [No Abstract] [Full Text] [Related]
10. Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders. Shimoni A; Nagler A Isr Med Assoc J; 2002 Apr; 4(4):272-9. PubMed ID: 12001702 [No Abstract] [Full Text] [Related]
15. Hereditary hypo/de-pigmented dermatoses: an overview. Sehgal VN; Srivastava G Int J Dermatol; 2008 Oct; 47(10):1041-50. PubMed ID: 18986352 [No Abstract] [Full Text] [Related]
16. Non-myeloblative stem-cell transplantation for immunotherapy of cancer and non-malignant diseases with allogeneic lymphocytes. Slavin S Isr Med Assoc J; 2002 Apr; 4(4):284-7. PubMed ID: 12001705 [No Abstract] [Full Text] [Related]
17. Newly revealed genome complexity may mean personalized medicine is farther away. Schmidt C J Natl Cancer Inst; 2007 Nov; 99(21):1568-70. PubMed ID: 17971520 [No Abstract] [Full Text] [Related]
20. [Fundamentals of the current diagnosis, prevention and treatment of hereditary diseases]. Davidenkova EF; Lantsov VA; Shvarts EI Vestn Akad Med Nauk SSSR; 1986; (9):8-13. PubMed ID: 3788280 [No Abstract] [Full Text] [Related] [Next] [New Search]